Larvol Delta - Evaluating-Safety-Tolerability-PharmacokineticEfficacy-of-WJ01024-or-WJ01024-Combined-With-Ruxolitinib-in-Patients-With-Myelofibrosis

JS110 - Shanghai Junshi Bioscience

Jakafi (ruxolitinib) - Incyte

http://clinicaltrials.gov/ct2/show/NCT07802405

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next